MedPath

3 PERIOD FASTING STUDY IN HEALTHY, ADULT, MALES, RANDOMLY DOSED IN EACH PERIOD WITH 2000mg OF CURCUMINOIDS FROM LIQUID CURCUMIN or with CURCUMINOID POWDER WITH TURMERIC ESSENTIAL OIL IN VEGETARIAN CAPSULES OR WITH CURCUMINOID POWDER WITH PIPERINE IN VEGETARIAN CAPSULES

Not Applicable
Completed
Registration Number
CTRI/2019/04/018513
Lead Sponsor
Halycon Bioscience pty Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
9
Inclusion Criteria

Healthy adult human volunteers of age between 18-45 years

Exclusion Criteria

Not provided

Study & Design

Study Type
BA/BE
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bio availabilityTimepoint: 14 time points, 00.00, 0.50, 01.00, 01.50, 02.00, 02.50, 03.00, 03.50, 04.00, 05.00, 06.00, 08.00, 10.00, 12.00
Secondary Outcome Measures
NameTimeMethod
To Monitor the adverse events and to ensure the safety and tolerability of the study subjectsTimepoint: 00.00, 0.50, 01.00, 01.50, 02.00, 02.50, 03.00, 03.50, 04.00, 05.00, 06.00, 08.00, 10.00, 12.00
© Copyright 2025. All Rights Reserved by MedPath